Ask AI

Capsule Slidesets

Share

Program Content

Activities

  • Ibrutinib ± R vs BR in Older CLL Patients
    A041202: Phase III Trial of Ibrutinib ± Rituximab vs Bendamustine + Rituximab in Older Patients With Previously Untreated CLL
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022
  • AUGMENT: R² in iNHL
    AUGMENT: Phase III Study of Rituximab/Lenalidomide vs Rituximab/Placebo for R/R Indolent Non-Hodgkin Lymphoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022
  • PET-Guided Tx in DLBCL
    Intergroup NCTN Study S1001: PET-Directed Therapy in Limited-Stage DLBCL
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 19, 2019

Provided by

ProCE Banner

Supporters

AbbVie

AstraZeneca

Celgene

Dova Pharmaceuticals

Gilead Text

Incyte

Janssen Biotech Pharmacyclics Abbvie

Jazz Pharmaceuticals, Inc.

Novartis Pharmaceuticals Corporation

Seagen

Takeda Oncology